Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients (Q31155150)

29 June 2017

1 reference

title

Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients (English)

1 reference

29 June 2017

1

Claudio Piersimoni

1 reference

29 June 2017

2

Claudio Scarparo

1 reference

29 June 2017

publication date

1 May 2008

1 reference

Lancet Infectious Diseases

29 June 2017

published in

1 reference

29 June 2017

volume

8

1 reference

29 June 2017

issue

5

1 reference

29 June 2017

page(s)

323-334

1 reference

Epidemiology of infection by nontuberculous mycobacteria

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

The new mycobacterial species--emerging or newly distinguished pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Newly described or emerging human species of nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Genetic dissection of immunity to mycobacteria: the human model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Lung disease due to the more common nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Diagnosis, differentiating colonization, infection, and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Conventional identification characteristics, mycolate and fatty acid composition, and clinical significance of MAIX AccuProbe-positive isolates of Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

The Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium avium complex pulmonary disease in patients without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Radiology of pulmonary Mycobacterium avium-intracellulare complex

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium avium complex lung disease in immunocompetent patients: radiography-CT correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Infection with Mycobacterium avium complex in patients without predisposing conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium avium-intracellulare pulmonary infection in patients without known predisposing lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium avium Complex Pulmonary Disease Presenting as an Isolated Lingular or Middle Lobe Pattern

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Lady Windermere syndrome: middle lobe bronchiectasis and Mycobacterium avium complex infection due to voluntary cough suppression.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Non-tuberculous mycobacteria in patients with bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Nontuberculous mycobacterial disease following hot tub exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Comparison of Prognosis of Pulmonary Diseases Caused by Mycobacterium avium and by Mycobacterium intracellulare

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Infection with Mycobacterium kansasii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium kansasii infections in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium malmoense sp. nov.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Infection with Mycobacterium malmoense in Sweden: report of 221 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium malmoense infections in the United States, January 1993 through June 1995

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium malmoense infections in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium malmoense: an easily missed pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Pulmonary infection with nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Increasing incidence of Mycobacterium xenopi at Bellevue hospital: An emerging pathogen or a product of improved laboratory methods?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Infections caused by Mycobacterium szulgai in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

First pulmonary case reported in Argentina of infection with mycobacterium szulgai, a rare pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium szulgai; a new pathogen causing infection of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Pulmonary infection due to Mycobacterium szulgai , case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Agents of newly recognized or infrequently encountered mycobacterial diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium simiae. Clinical features and follow-up of twenty-four patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Clinical and microbiological assessment of Mycobacterium simiae isolates from a single laboratory in southern Arizona

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Characterization of mycobacterial isolates phylogenetically related to, but different from Mycobacterium simiae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Misidentification and diagnostic delay Caused by a false-positive amplified Mycobacterium tuberculosis direct test in an immunocompetent patient with a Mycobacterium celatum infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium celatum pulmonary infection in the immunocompetent: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium celatum, an emerging pathogen and cause of false positive amplified Mycobacterium tuberculosis direct test

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Isolation of Mycobacterium celatum from patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Comparison of methods for Identification of Mycobacterium abscessus and M. chelonae isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Laboratory diagnosis of mycobacterial infections: new tools and lessons learned

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Results of operation in Mycobacterium avium-intracellulare lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Elimination of Mycobacterium Intracellulare from Sputum after Bronchial Hygiene

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Thrice-Weekly Clarithromycin-Containing Regimen for Treatment of Mycobacterium kansasii Lung Disease: Results of a Preliminary Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Radiometric susceptibility testing of Mycobacterium xenopi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

Pneumonectomy for nontuberculous mycobacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970100-2

7 January 2021

10.1016/S1473-3099(08)70100-2

Identifiers

DOI

1 reference

29 June 2017

1 reference